Karmanos Cancer Institute Unites Operational Teams and Creates Optimized Processes
Discover how Karmanos Cancer Institute used Advarra Insights to unify teams, optimize operations, and maximize the impact of their data.
Technology
Integration Update: Recent Milestones Completed
The Advarra team has worked to fully integrate our processes and policies to provide clients with unified capabilities and support
Integration Update: Expanded FAQ for Advarra Merger Efforts
The Advarra team (formerly Chesapeake IRB and Schulman IRB) continues to integrate our processes and policies, leveraging mutual strengths in
Clinical Research Acronyms and Abbreviations You Should Know
New to clinical research? Learn the meaning of common industry acronyms and abbreviations including eCRF, IIT, PI, TMF, and more.
Integration Update: Revised FAQ for Advarra Merger Efforts
Since November 2017, the Advarra team (formerly Chesapeake IRB and Schulman IRB) has been working to integrate our processes and
Data Collection in Clinical Trials: 4 Steps for Creating an SOP
Learn the necessary steps to create an effective SOP for data collection in clinical trials.
Schulman IRB and Chesapeake IRB Merger and Integration: What You Need to Know
On November 7, 2017, we announced that Chesapeake IRB and Schulman IRB are merging under the new organizational name, Advarra.
The Six Characteristics of an NCI-Designated Cancer Center
Learn the key characteristics that all NCI-designated cancer centers have in common.
6 Ways Sponsors Can Improve Feasibility Questionnaires
Creating feasibility assessments can be as frustrating for sponsors as answering questionnaires is for sites. Here’s how sponsors can alleviate these frustrations, according to sites.
Deciphering the CRC Career Path: Key Skills and Responsibilities
Wendy Tate, Director of Data Analytics at Forte, explains key skills and experiences sites look for in a clinical research coordinator.
Beginner’s Guide to Clinical Trial Performance Metrics
Basics to help you get started measuring and improving your clinical trial performance.